Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

    NEXT STORY
    Gentherm Provides Update Related to COVID-19
    PREV STORY
    Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    FDA approves Roche’s Rituxan (rituximab) in children with two rare blood vessel disorders

    author_avatar
    NASDAQ Market News

    Update: Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens

    author_avatar
    NASDAQ Market News

    BeiGene to Present at the Cowen and Company 37th Annual Health Care Conference

    CAMBRIDGE, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News